Cargando…

Cholangiocarcinoma as an Indication for Liver Transplantation in the Era of Transplant Oncology

Cholangiocarcinoma (CCA) arises from the biliary tract epithelium and accounts for 10–15% of all hepatobiliary malignancies. Depending on anatomic location, CCA is classified as intrahepatic (iCCA), perihilar (pCCA) and distal (dCCA). The best treatment option for pCCA is liver resection and when a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gringeri, Enrico, Gambato, Martina, Sapisochin, Gonzalo, Ivanics, Tommy, Lynch, Erica Nicola, Mescoli, Claudia, Burra, Patrizia, Cillo, Umberto, Russo, Francesco Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290472/ https://www.ncbi.nlm.nih.gov/pubmed/32380750 http://dx.doi.org/10.3390/jcm9051353

Ejemplares similares

Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation
por: Pelizzaro, Filippo, et al.
Publicado: (2021)

Invasive fungal infection before and after liver transplantation
por: Ferrarese, Alberto, et al.
Publicado: (2020)

Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies
por: Catanzaro, Elisa, et al.
Publicado: (2023)

Long-Term Impact of Direct-Acting Antivirals on Liver Fibrosis and Survival in HCV-Infected Liver Transplant Recipients
por: Gambato, Martina, et al.
Publicado: (2023)

Unchanged surgical management of patients with Cholangiocarcinoma during the COVID-19 pandemic
por: Gringeri, Enrico, et al.
Publicado: (2020)

Colon Rectal Liver Metastases: The Role of the Liver Transplantation in the Era of the Transplant Oncology and Precision Medicine
por: Finotti, Michele, et al.
Publicado: (2021)

Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy
por: Ferrarese, Alberto, et al.
Publicado: (2022)

The management of post-transplantation recurrence of hepatocellular carcinoma
por: Rajendran, Luckshi, et al.
Publicado: (2022)

New Indications for Liver Transplantation
por: Zanetto, Alberto, et al.
Publicado: (2021)

Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study
por: Ferrarese, Alberto, et al.
Publicado: (2018)

The New Era of Transplant Oncology: Liver Transplantation for Nonresectable Colorectal Cancer Liver Metastases
por: Gorgen, Andre, et al.
Publicado: (2018)

Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management
por: Battistella, Sara, et al.
Publicado: (2023)

Sustained Complete Response after Biological Downstaging in Patients with Hepatocellular Carcinoma: XXL-Like Prioritization for Liver Transplantation or “Wait and See” Strategy?
por: Vitale, Alessandro, et al.
Publicado: (2021)

The Role of Antiviral Prophylaxis in Preventing HBV and HDV Recurrence in the Setting of Liver Transplantation
por: Battistella, Sara, et al.
Publicado: (2023)

Recent advances in liver transplantation for cancer: The future of transplant oncology
por: Abreu, Phillipe, et al.
Publicado: (2019)

Robotic hepatectomy and biliary reconstruction for perihilar cholangiocarcinoma: a pioneer western case series
por: Cillo, Umberto, et al.
Publicado: (2021)

Impact of Positive Radial Margin on Recurrence and Survival in Perihilar Cholangiocarcinoma
por: D’Amico, Francesco Enrico, et al.
Publicado: (2022)

Management of bacterial infection in the liver transplant candidate
por: Ferrarese, Alberto, et al.
Publicado: (2018)

Translational Value of Tumor-Associated Lymphangiogenesis in Cholangiocarcinoma
por: Cadamuro, Massimiliano, et al.
Publicado: (2022)

An international multicentre evaluation of treatment strategies for combined hepatocellular-cholangiocarcinoma(✰)()
por: Claasen, Marco P.A.W., et al.
Publicado: (2023)

Clinical implications of COVID-19 in patients with chronic liver disease and liver tumor
por: Gambato, Martina, et al.
Publicado: (2020)

Trends in liver transplantation for autoimmune liver diseases: a Canadian study
por: Murillo Perez, Carla F., et al.
Publicado: (2022)

Expanding indications for liver transplantation in the era of liver transplant oncology
por: Panayotova, Guergana, et al.
Publicado: (2021)

Surgery for cholangiocarcinoma
por: Cillo, Umberto, et al.
Publicado: (2019)

European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular Carcinoma
por: Claasen, Marco Petrus Adrianus Wilhelmus, et al.
Publicado: (2023)

Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors
por: Ballarin, Roberto, et al.
Publicado: (2017)

Combined proteomic/transcriptomic signature of recurrence post-liver transplantation for hepatocellular carcinoma beyond Milan
por: Bhat, Mamatha, et al.
Publicado: (2021)

Impact of bacterial infections prior to liver transplantation on post-transplant outcomes in patients with cirrhosis
por: Incicco, Simone, et al.
Publicado: (2023)

Preoperative neutrophil-to-lymphocyte ratio is prognostic for early recurrence after curative intrahepatic cholangiocarcinoma resection
por: Choi, Woo Jin, et al.
Publicado: (2023)

Influence of Hepatocellular Carcinoma on Platelet Aggregation in Cirrhosis
por: Zanetto, Alberto, et al.
Publicado: (2021)

OC.04.8 IMPACT OF COVID-19 PANDEMIC ON REFERRAL OF PATIENTS WITH LIVER DISEASE TO A LIVER TRANSPLANT CENTER
por: Germani, G., et al.
Publicado: (2021)

National time trends in mortality and graft survival following liver transplantation from circulatory death or brainstem death donors
por: Wallace, David, et al.
Publicado: (2021)

Pushing the limits for the surgical treatment of intrahepatic cholangiocarcinoma
por: Choi, Woo Jin, et al.
Publicado: (2023)

Hepatocellular Carcinoma: The Role of Immunotherapy and Transplantation in the Era of Transplant Oncology
por: Alghamdi, Saad, et al.
Publicado: (2023)

New Perspectives in Liver Transplantation: From Regeneration to Bioengineering
por: Bizzaro, Debora, et al.
Publicado: (2019)

Immune Activation, Exhaustion and Senescence Profiles as Possible Predictors of Cancer in Liver Transplanted Patients
por: Petrara, Maria Raffaella, et al.
Publicado: (2022)

Intrahepatic Cholangiocarcinoma Developing in Patients with Metabolic Syndrome Is Characterized by Osteopontin Overexpression in the Tumor Stroma
por: Cadamuro, Massimiliano, et al.
Publicado: (2023)

SerpinB3 as hepatic marker of post-resective shear stress
por: Gringeri, Enrico, et al.
Publicado: (2023)

Newest Therapies for Cholangiocarcinoma: An Updated Overview of Approved Treatments with Transplant Oncology Vision
por: Zhang, Yuqi, et al.
Publicado: (2022)

Editorial: Liver transplantation for liver cancer in the era of transplant oncology: accurate diagnosis and treatment
por: Xiang, Ze, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0ikhquf1f7m39tkth6okg8d94q